Net Income 更改
Gilead Sciences USD 1.43B 751M 2023-12
RedHill Biopharma USD 761K 49.48M 2023-06
Supernus Pharmaceuticals USD 1.18M 17.15M 2023-12



Intra Cellular Therapies 净收入 - 当前值,历史数据,预测,统计,图表和经济日历 - May 2024.